Health Canada Approves 4Moving Biotech’s Phase 2a OA Trial
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatment that modify the natural history of knee osteoarthritis, announces that it has been...
Category : Healthcare and Pharmaceutical
Fangzhou Inc. Partners with Tencent to Boost AI Healthcare
Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in Internet healthcare solutions, announced a strategic collaboration with Tencent Health and Tencent Cloud to accelerate AI-driven healthcare solutions by...
Neurim Gets EU Approval for Slenyto® in ADHD Pediatric Insomnia
Neurim Pharmaceuticals (“Neurim”) announces that the European Commission has approved the extension of the indication to include the treatment of insomnia in children with attention deficit...
Asgard Therapeutics names Shane Olwill as CDO
Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announces the appointment of experienced immunology drug development specialist Shane Olwill as...
PatchMD Launches Mito Cocktail Patch for ASD Mitochondrial Health
PatchMD, a leader in innovative nutrient delivery systems, proudly announces the launch of its new Mito Cocktail Patch, designed to support mitochondrial function for individuals with...
Morningside Ventures Invests in Xealth to Boost Digital Health
Strategic investment will further the creation of a digitally-enabled care delivery system, bringing digital interventions within clinician workflows and to specific populations Xealth, the leader...
Ant Group Unveils AI Healthcare Upgrades for Hospitals & Users
Ant Group has announced major upgrades to its comprehensive suite of AI solutions for the healthcare sector, aiming to enhance the capabilities of hospitals and...
Newron Nominates Dr. Chris Martin as Independent Chairman
Expected to succeed Dr. Ulrich Köstlin who has notified Newron of his intention to retire after 12 years of service as Chairman of its Board...
Novotech Named Best CRO in Australia at Asia-Pacific Awards
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path...
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
Medical device, pharmaceutical, and life sciences expert tapped to lead Company’s technology strategy and global engineering organization Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”),...
IFF Pharma Solutions Unveils Next-Gen Excipient Innovations
Global Leading Excipient Supplier to Highlight Innovations in Oral Disintegrating Tablets, Controlled Release Formulations, and Low-Nitrite Solutions IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge...
Bio-Techne to Showcase RNAscope Advances at 2025 USCAP Meeting
Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet...
Tempero Bio Secures $70M to Advance TMP-301 for Phase 2 Trials
Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The financing...
VantAI Launches Neo-1, First AI for Molecular Interaction Design
VantAI today unveiled Neo-1, the world’s most advanced atomistic foundation model and the first to unify de novo molecular generation with multimodal structure prediction, at...
Omeros Provides Update on Zaltenibart Phase 3 PNH Trial
— Phase 3 Data Needed for BLA Submission Expected in the Fourth Quarter 2026 — Omeros Corporation (Nasdaq: OMER) today reported that clinical trial site...